Pharmaceutical company Merck said Friday it will seek authorisation in the US for an oral drug for Covid-19, after the pill showed “compelling results” in a clinical trial. The experimental drug, molnupiravir, significantly reduced the risk of hospitalisation or death when administered to high-risk patients early in the disease, Merck and its partner Ridgeback Biotherapeutics […]
The post Merck to seek authorisation for oral Covid-19 drug appeared first on BOL News.
from Sci-Tech – BOL News https://ift.tt/3abing9
No comments:
Post a Comment